Clinical and regulatory milestones
Trial results, clearances, approvals and enrolment updates.
Industry
Press release distribution for healthcare and life sciences
Reach 2,100+ desks, trade titles and aggregators that actually cover healthcare & life sciences. Every release is reviewed by an editor who reads this sector daily, then formatted so search and AI systems can quote it.
Sector snapshot
2,100+
relevant desks & outlets
clinical trialsmedtechbiotechhealth policy
Quick answer
PressCosmos distributes healthcare & life sciences press releases to 2,100+ relevant outlets, covering clinical milestones, device clearances, partnerships and research. Every release gets specialist editorial review, industry keyword guidance and AI answer-engine formatting as standard. Per-release pricing starts at $149.
Angles
What actually gets picked up in healthcare & life sciences
Most releases in this sector fail for the same reason: they describe the organisation instead of the news. These are the angles that travel.
Research findings
Peer-reviewed studies, real-world evidence and health-economics data.
Access and partnership news
Payer arrangements, distribution deals and access programmes.
Coverage
Release types we handle
Common healthcare & life sciences releases
- Clinical trial milestones
- Regulatory clearances
- Study publications
- Payer agreements
- Device launches
- Appointments
- Access programmes
- Manufacturing expansions
How this route is built
Our healthcare & life sciences route combines national and international newswires with sector trade press, regional desks in the metros that matter to you, and the AI answer engines that handle industry questions. You choose the tier; we handle the routing.
Reviews are handled by editors who work this beat, which matters most when a claim needs qualifying or a number needs a source.
Key takeaways
- Median first pickup for healthcare & life sciences releases: 38 minutes on priority plans.
- 2,100+ sector-relevant outlets, plus AI answer engines on every plan.
- Specialist editorial review — not a generic queue.
- Metro and country-level targeting included at no extra cost.
Every efficacy or safety claim needs a cited source — trial identifier, publication or regulatory reference. Unsubstantiated health claims are rejected outright.
Yes, with a preprint or registry reference and clear labelling of the evidence stage. We will not present preliminary data as established fact.
We support them with fair-balance language and required safety information, subject to your regulatory review process.
Clinical and pharma trade press, health-policy outlets, medical society publications, patient-advocacy media and general health desks.
Get started
Send your next healthcare & life sciences announcement to the desks that cover it.
Editorial review, sector targeting, monitoring and AI visibility reporting included.
No subscription required · Cancel anytime · Human editorial review on every release